Healthcare -
Biotechnology - NASDAQ - US
$ 0.885
-3.51 %
$ 6.59 M
Market Cap
-0.08
P/E
KTTA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities KTTA - Pasithea Therapeutics Corp.
4.52 B
LAST VALUE
3656.34%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR